INVO Ebitda from 2010 to 2026

IVF Stock   1.16  0.08  6.45%   
INVO Fertility's EBITDA is decreasing over the last several years with slightly volatile swings. EBITDA is estimated to finish at about -6.1 M this year. During the period from 2010 to 2026 INVO Fertility EBITDA regressed destribution of quarterly values had mean deviationof  2,702,181 and mean square error of 3.4 T. View All Fundamentals
 
EBITDA  
First Reported
2007-03-31
Previous Quarter
-2.8 M
Current Value
-1.5 M
Quarterly Volatility
2.3 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check INVO Fertility financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among INVO Fertility's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Selling General Administrative of 7.6 M or Other Operating Expenses of 17.7 M, as well as many indicators such as Price To Sales Ratio of 12.08, Dividend Yield of 0.0 or PTB Ratio of 6.19. INVO financial statements analysis is a perfect complement when working with INVO Fertility Valuation or Volatility modules.
  
Build AI portfolio with INVO Stock
Check out the analysis of INVO Fertility Correlation against competitors.
For more detail on how to invest in INVO Stock please use our How to Invest in INVO Fertility guide.
The Ebitda trend for INVO Fertility offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether INVO Fertility is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest INVO Fertility's Ebitda Growth Pattern

Below is the plot of the Ebitda of INVO Fertility over the last few years. It is INVO Fertility's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in INVO Fertility's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

INVO Ebitda Regression Statistics

Arithmetic Mean(3,744,923)
Coefficient Of Variation(82.99)
Mean Deviation2,702,181
Median(2,628,870)
Standard Deviation3,107,783
Sample Variance9.7T
Range10.7M
R-Value(0.82)
Mean Square Error3.4T
R-Squared0.67
Significance0.000065
Slope(502,194)
Total Sum of Squares154.5T

INVO Ebitda History

2026-6.1 M
2025-6.4 M
2024-7.1 M
2023-6.9 M
2022-10.8 M
2021-5.2 M
2020-5.5 M

About INVO Fertility Financial Statements

INVO Fertility stakeholders use historical fundamental indicators, such as INVO Fertility's Ebitda, to determine how well the company is positioned to perform in the future. Although INVO Fertility investors may analyze each financial statement separately, they are all interrelated. For example, changes in INVO Fertility's assets and liabilities are reflected in the revenues and expenses on INVO Fertility's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in INVO Fertility. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA-6.4 M-6.1 M

Currently Active Assets on Macroaxis

When determining whether INVO Fertility is a strong investment it is important to analyze INVO Fertility's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact INVO Fertility's future performance. For an informed investment choice regarding INVO Stock, refer to the following important reports:
Check out the analysis of INVO Fertility Correlation against competitors.
For more detail on how to invest in INVO Stock please use our How to Invest in INVO Fertility guide.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does INVO have expansion opportunities? Factors like these will boost the valuation of INVO Fertility. Market participants price INVO higher when confident in its future expansion prospects. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating INVO Fertility demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share
(105.51)
Revenue Per Share
10.916
Quarterly Revenue Growth
0.039
Understanding INVO Fertility requires distinguishing between market price and book value, where the latter reflects INVO's accounting equity. The concept of intrinsic value—what INVO Fertility's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push INVO Fertility's price substantially above or below its fundamental value.
Please note, there is a significant difference between INVO Fertility's value and its price as these two are different measures arrived at by different means. Investors typically determine if INVO Fertility is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, INVO Fertility's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.